Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
7.31
-0.16 (-2.14%)
At close: Mar 18, 2026, 4:00 PM EDT
7.46
+0.15 (2.05%)
After-hours: Mar 18, 2026, 7:56 PM EDT
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $643.35 million as of March 18, 2026. Its market cap has increased by 215.37% in one year.
Market Cap
643.35M
Enterprise Value
583.95M
1-Year Change
215.37%
Ranking
Category
Stock Price
$7.31
Market Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $643.35M, an increase of 85.30%. That is a compound annual growth rate of 13.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 657.43M | 55.77% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 684.30M |
| Lexicon Pharmaceuticals | 682.13M |
| Design Therapeutics | 677.78M |
| LB Pharmaceuticals | 669.41M |
| Prime Medicine | 662.63M |
| MiMedx Group | 655.18M |
| ProKidney | 646.79M |
| Eikon Therapeutics | 645.11M |